Pathfinder

Read the reports from our extensive research programme into the current landscape of ovarian cancer.

Pathfinder is Target Ovarian Cancer's ground-breaking research that provides a detailed picture of the experiences of people with ovarian cancer in the UK. 

Our latest report, Pathfinder 2022: Faster, further, and fairer, tells us that progress is possible if urgent action is taken now.

It reveals that if diagnosis was faster, further support was available and access to treatment was fairer, there could be potential for more women to survive, live well with ovarian cancer and be supported from diagnosis and throughout treatment.

Pathfinder 2022

What did we find out?

Pathfinder 2022 discovered that

  • 1/3

    1/3

    Of women are still waiting

    over three months for a diagnosis of ovarian cancer

  • 54%

    54%

    Of people diagnosed were not

    asked by anyone involved in their treatment about the impact on their mental health

  • 11%

    11%

    Of women waited

    32 days or more to receive an ultrasound scan

Take action

We need you to email your MP to ask them to work with us to raise the profile of ovarian cancer and the devastating impact it’s having on people’s lives. 

It’s a quick and easy task, but the difference you’ll make is enormous! 

Email your MP now

Read our previous reports

Pathfinder is Target Ovarian Cancer's ground-breaking research that provides a detailed picture of the experiences of people with ovarian cancer in the UK.